
While not illegal, some people are vehemently opposed to the practice.
While not illegal, some people are vehemently opposed to the practice.
Cuts were made in areas not focused on clinical trials.
The company received approval in the Netherlands to start dosing humans with one of its compounds.
Some analysts have called the industry's business model problematic.
Also a peek at their plans for the year ahead.
Scientific community looks for ways to effectively research psilocybin.
Researchers looking more closely at similarities of compounds and responses.
Even without revenue, psychedelics companies find financing for ongoing research.
Despite a challenging economy, psychedelics companies have accelerated development.
Any analyst knows that market-reactive swings aren’t really a true indicator of what is going on inside a company.
Unpack the industry with the daily cannabis newsletter for business leaders.
Unpack the industry with the daily cannabis newsletter for business leaders.